Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness

Por Johnsen, Erik, Kroken, Rune A.
Publicado em 2012

Priapism in Antipsychotic Drug Use: A Rare but Important Side Effect

Por Sinkeviciute, Igne, Kroken, Rune A., Johnsen, Erik
Publicado em 2012

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone

Por Johnsen, Erik, Kroken, Rune A, Wentzel-Larsen, Tore, Jørgensen, Hugo A
Publicado em 2010

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE

Por Drosos, Petros, Johnsen, Erik, Bartz-Johannessen, Christoffer A, Kroken, Rune A
Publicado no Schizophr Bull (2020)

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

Por Kroken, Rune A, Johnsen, Erik, Ruud, Torleif, Wentzel-Larsen, Tore, Jørgensen, Hugo A
Publicado em 2009

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

Por Kjelby, Eirik, Jørgensen, Hugo A, Kroken, Rune A, Løberg, Else-Marie, Johnsen, Erik
Publicado em 2011

Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics

Por Kroken, Rune A., Sommer, Iris E., Steen, Vidar M., Dieset, Ingrid, Johnsen, Erik
Publicado no Front Psychiatry (2019)

T16. SCHIZOPHRENIA SPECTRUM DISORDER: DEPRESSION TRAJECTORIES AND IMMUNE MARKERS

Por Hoprekstad, Gunnhild, Gjestad, Rolf, Kjelby, Eirik, Skrede, Silje, Johnsen, Erik, Kroken, Rune A
Publicado no Schizophr Bull (2020)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement

Por Anda, Liss, Brønnick, Kolbjørn S., Johnsen, Erik, Kroken, Rune A., Jørgensen, Hugo, Løberg, Else-Marie
Publicado no PLoS One (2016)

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study

Por Johnsen, Erik, Sinkeviciute, Igne, Løberg, Else-Marie, Kroken, Rune A, Hugdahl, Kenneth, Jørgensen, Hugo A
Publicado em 2013

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics

Por Johnsen, Erik, Aanesen, Kristina, Sriskandarajah, Sanjeevan, Kroken, Rune A., Løberg, Else-Marie, Jørgensen, Hugo A.
Publicado em 2013

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability

Por Løberg, Else-Marie, Helle, Siri, Nygård, Merethe, Berle, Jan Øystein, Kroken, Rune A., Johnsen, Erik
Publicado no Front Psychiatry (2014)

Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies

Por Kroken, Rune A., Kjelby, Eirik, Wentzel-Larsen, Tore, Mellesdal, Liv S., Jørgensen, Hugo A., Johnsen, Erik
Publicado no Ther Adv Psychopharmacol (2014)

M47. AKATHISIA AND ATYPICAL ANTIPSYCHOTICS: EXPLORING ASSOCIATIONS TO SUICIDALITY AND AGITATION

Por Bjarke, Jill, Gjerde, Helga Nødland, Løberg, Else-Marie, Jørgensen, Hugo A, Kroken, Rune A, Johnsen, Erik
Publicado no Schizophr Bull (2020)

F184. TESTING THE GABA-GLUTAMATE HYPOTHESIS FOR SCHIZOPHRENIA IN RELATION TO AUDITORY HALLUCINATIONS - PRELIMINARY RESULTS

Por Hjelmervik, Helene, Craven, Alexander R, Johnsen, Erik, Kompus, Kristiina, Kroken, Rune A, Løberg, Else-Marie, Hugdahl, Kenneth
Publicado no Schizophr Bull (2018)

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016

Por Højlund, Mikkel, Pottegård, Anton, Johnsen, Erik, Kroken, Rune A., Reutfors, Johan, Munk‐Jørgensen, Povl, Correll, Christoph U.
Publicado no Br J Clin Pharmacol (2019)

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use

Por Løberg, Else-Marie, Nygård, Merethe, Berle, Jan Øystein, Johnsen, Erik, Kroken, Rune A., Jørgensen, Hugo A., Hugdahl, Kenneth
Publicado em 2012

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use

Por Løberg, Else-Marie, Nygård, Merethe, Berle, Jan Øystein, Johnsen, Erik, Kroken, Rune A., Jørgensen, Hugo A., Hugdahl, Kenneth
Publicado em 2013

A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation

Por Kroken, Rune A., Løberg, Else-Marie, Drønen, Tore, Grüner, Renate, Hugdahl, Kenneth, Kompus, Kristiina, Skrede, Silje, Johnsen, Erik
Publicado em 2014

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis

Por Johnsen, Erik, Fathian, Farivar, Kroken, Rune A., Steen, Vidar M., Jørgensen, Hugo A., Gjestad, Rolf, Løberg, Else-Marie
Publicado no BMC Psychiatry (2016)